Clinical Trial Update: Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1% [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating clinical endpoints for two diclofenac sodium 1% gel formulations in osteoarthritis of the knee. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• Diclofenac Sodium Gel 1% (diclofenac sodium)

Snippet

Sponsor: Anchen Pharmaceuticals, Inc | Conditions: Osteo Arthritis of the Knee | Phase 3 | Status: COMPLETED